SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) insider Anthony J. Recupero sold 5,461 shares of SI-BONE stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $17.69, for a total value of $96,605.09. Following the sale, the insider now directly owns 203,835 shares in the company, valued at approximately $3,605,841.15. The sale was disclosed in a document filed with the SEC, which is available at this link.
SI-BONE Price Performance
Shares of SI-BONE stock traded up $0.50 during midday trading on Monday, hitting $18.04. 230,933 shares of the company were exchanged, compared to its average volume of 355,422. The firm has a 50 day simple moving average of $18.93 and a 200-day simple moving average of $22.72. The company has a debt-to-equity ratio of 0.21, a current ratio of 10.89 and a quick ratio of 9.74. SI-BONE, Inc. has a 52 week low of $11.14 and a 52 week high of $29.51. The firm has a market cap of $730.64 million, a P/E ratio of -15.16 and a beta of 0.99.
Analysts Set New Price Targets
Several brokerages have recently weighed in on SIBN. Truist Financial decreased their price objective on SI-BONE from $33.00 to $31.00 and set a “buy” rating on the stock in a report on Tuesday, August 8th. Needham & Company LLC decreased their price objective on SI-BONE from $32.00 to $25.00 and set a “buy” rating on the stock in a report on Tuesday, November 7th. Cantor Fitzgerald decreased their price objective on SI-BONE from $30.00 to $25.00 and set an “overweight” rating on the stock in a report on Tuesday, November 7th. Finally, Morgan Stanley decreased their price objective on SI-BONE from $30.00 to $25.00 and set an “overweight” rating on the stock in a report on Tuesday, November 7th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $27.17.
Hedge Funds Weigh In On SI-BONE
Several institutional investors have recently bought and sold shares of SIBN. FMR LLC raised its position in SI-BONE by 28.7% in the 1st quarter. FMR LLC now owns 2,160 shares of the company’s stock valued at $42,000 after purchasing an additional 482 shares during the last quarter. Harbor Capital Advisors Inc. bought a new position in SI-BONE in the 2nd quarter valued at $47,000. Ensign Peak Advisors Inc bought a new position in SI-BONE in the 3rd quarter valued at $48,000. Larson Financial Group LLC bought a new position in SI-BONE in the 1st quarter valued at $49,000. Finally, Coppell Advisory Solutions LLC bought a new position in SI-BONE in the 2nd quarter valued at $50,000.
SI-BONE Company Profile
SI-BONE, Inc, a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma.
- Five stocks we like better than SI-BONE
- Investing in Construction Stocks
- The most upgraded stocks in November have two things in common
- How to Invest in Lithium and Lithium Stocks
- Monday.com rocked earnings like it’s the weekend
- How to Invest in Canada for Beginners
- Plan to own one retailer? Make it this one
Receive News & Ratings for SI-BONE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-BONE and related companies with MarketBeat.com's FREE daily email newsletter.